Latus Bio, Inc.
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2
$97MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2
Develops novel therapies for behavioral symptoms associated with Alzheimer's Disease
Develops AI-driven drug discovery for proximity therapeutics
Pitching Modi Ventures? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room